Abingworth as of March 31, 2020
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Personalis Ord (PSNL) | 29.0 | $44M | 5.4M | 8.00 | |
Phathom Pharmaceuticals (PHAT) | 20.5 | $31M | 1.2M | 25.62 | |
Crispr Therapeutics (CRSP) | 14.6 | $22M | 519k | 42.28 | |
Soleno Therapeutics | 10.4 | $16M | 7.0M | 2.25 | |
Exicure | 6.8 | $10M | 7.0M | 1.46 | |
Sierra Oncology | 5.7 | $8.6M | 877k | 9.80 | |
Sientra | 3.1 | $4.7M | 2.4M | 1.96 | |
Verona Pharma Plc ads (VRNA) | 2.5 | $3.7M | 902k | 4.12 | |
Paratek Pharmaceuticals | 2.2 | $3.2M | 1.0M | 3.11 | |
Molecular Templates | 1.8 | $2.6M | 200k | 13.21 | |
Artara Therapeutics | 1.7 | $2.6M | 114k | 23.00 | |
Chiasma | 0.9 | $1.3M | 371k | 3.63 | |
Aeglea Biotherapeutics | 0.7 | $1.1M | 241k | 4.59 | |
Obseva Sa | 0.1 | $210k | 88k | 2.39 | |
Cymabay Therapeutics | 0.1 | $191k | 131k | 1.46 | |
Histogenics Corp Cmn | 0.0 | $2.0k | 7.1k | 0.28 |